LUNG CANCER NURSING UK Expl1n8 the expÈiien(# and nEe*il never 5moke5 With Lcitkwi LUNG CANCÈ 'NURSING Ihi Annual Report and Accounts Financial Year ending January 2026 li ancer Nursing UK | FIFTEEN Ro5ehi LSLE, CAI 2RW Mqnt te
Trustees, Report | For the year ending January 2026 About LCNUK Lung Cancer Nursing UK was estabLished in 1998 to support the advancement of health by providing nurses who specialise in the treatment of patients with Lung cancer or mesothelioma with support, education and the opportunity to communicate and network with peers.. and to provide a nationaL voice on clinical and strategic issues for specialist Lung cancer nurses. The organisation became a charitable incorporated organisation (CIO) in 2015. Membership is open to any specialist nurse who spends more than 50Vo of their working week or clinical activities in caring for patients with lung cancer and or mesothelioma. Associate membership is open to those who do not meet this criteria. The experience and clinical background of the members working environments are very diverse, including, palliative care, oncology (cancer centres or units) respiratory medicine, community and others, this affords the organisation a wealth of knowledge in to which members can access. The actlvltles of the CIO fall Into four dlstlnct categorfes these are as follow& Clinical Improving the care lung cancer patients receive Disseminating best practice and sharing information and knowledge DeveLopmental Keeping members up-to-date with the latest Lung cancer news through our e-buLletins Highlighting new developments in the UK Encouraging regional participation within LCNUK Education Providing a forum to disseminate new developments, skills, treatments and practice through educationaL programmes, annual conference, resources and pubLications Sharing cLinical updates and best practice with members Supporting and fostering audit and research in lung cancer and within the role of the LCNS Professional Provid ing support and networking, infrastructure and opportunities Campaigning for and supporting the role of the lung cancer nurse specialist Providing a voice on clinical and strategic issue5. H ighlighting the specialist role of nurses in cari ng for people with Lung cancer and mesothelioma Representing Lung cancer nurse speciaLists on nationaL and international bodies and organ isations Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 2025 Business Priorities The Trustees present their annual report together with the f inancial statements of the charity for the year l February 2025 to 31 January 2026. The Trustees confirm that the Annual Report and Financial Statements of the charity comply with the current statutory requirements, the requirements of the charity's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing thei r accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of IreLand {FRS102) (effective l January 2019). The Trustees have complied with the duty in part I section 4 of the Charities Act 2011 to have due regard to pubLic benefit guidance published by the Charity Commission. A detailed report of the activities undertaken and achievements by the Charity to further its charitable purposes for the public benef it is given below. In 2025 LCNUK had the following business priorities: ProfessionaL To act as advocates for patients with lung cancer on national professionaL bodies such as NICE/BTOG. To represent the Lung cancer nurse specialist on professional bodies and committees and provide a voice on strategic issues at a regional and national LeveL To promote the Lung cancer nurse specialist role and its benefits on an internationaL platform. To share best practice in lung cancer and mesothelioma care. DeveLopmentaL To ensure production and circulation of a monthLy e-bulleti n to share best practice and highlight lung cancer and reLevant nursing news and events. To maintain the LCNUK website creating, sharing and signposting to relevant news and events. Education and clinical Annual Conference June 2025 - To provide ongoing professional education to Lung cancer nurse speciaListS through its annual conference. To provide regular educationaL programmes of activity for members and associate members. Research To support ongoing research programmes with academic institutions and provide small research grants to support lung cancer nurse specialists taking their fi rst steps in research and those seeking advanced care practitioner status. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 2025 Impact report In 2025, workforce pressures continued relentlessly to impact on Lung Cancer Nurse Specialists. The UK Lung Cancer CoaLition (UKLCC) reported in 2025 that the lung cancer nurse specialist case Load typically ranges from 100 - 200 patients per nurse, and that this level is insufficient to meet demand. LCNUK has responded to these pressures by adapting its programmes and delivering education through short-form digital content, webinars and podcasts to support ongoing professional deveLopment. In spite of the challenges, the LCNUK annual conference continued to be weLL attended and is seen as a highlight of the professional year for our members. In 2025, we introduced associate membership for lung cancer navigators and developed a dedicated programme of education and practical tools to support this vital workforce incLuding a professional framework to guide Lung Cancer Navigators/Coordinators, their line managers and empLoyers on the core skiLLs, knowledge and training that they will gain and demonstrate as they progress in the role. Navigators play a key role alongside lung cancer nurse speciaLists in deliveri ng h igh-quality lung cancer care. They are an essentiaL part of the pathway, helping to ensure that patients, needs are prioritised and that their care journey is as seamless as possible. Membership numbers have increased sLightly in the business year and continue to hoLd strong following growth and increased retention after COVID. The charity is continuing to work on deveLoping innovative programmes to attract new members. Membership 2025 2024 2023 2022 2021 2020 2019 New 83 95 113 86 50. 82 Renewed 211 206 178 179 282. 156" 180 Expired/ cancelled 148 127 114 150 113 71 'Any member who paid for a membership in 2020, ha5 had their membership end dale extended to 2022 Professional Influencing and contribution to national poLicy LCNUK works alongside numerous organisations across the UK to inform lung cancer policy, promote best practice and act as the patients advocate for people with Lung cancer. In 2025, we continued to collaborate with national bodies including NICE, BTOG. UKLCC, Roy Castle Lung Cancer Foundation and other lung cancer related organisations to support the development of national policy and guideLines. The organisation has continued to support Lung Cancer Europe activities which have had number of initiatives taking pLace and members have submitted abstracts to the IASLC WorLd Conference on Lung Cancer. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 Representation British Thoracic Oncology Group GlobaL Lung Cancer Coalition I nternational Thoracic Oncology Nurses Forum Lung Cancer Europe Mesothelioma UK National Lung Cancer Audit National Institute for Health and Care Excellence Roy Castle Lung Cancer CoaLition Scottish Medicines Consortium Scottish Lung Cancer Nurses Forum UK Lung Cancer Coalition Welsh Lung Cancer Nurses Forum During 2025, LCNUK implemented a programme to evaLuate a tool to measure complexity in patients with lung cancer. The tool was assessed by group of members as part of the LCNUK annual workshop. The tool. based on The Patient Complexity Instrument" and the Macmillan Palliative Care Concerns HNA,, demonstrated that complexity increases with cancer stage and more nursing time is needed at stage 4. The strong correlation between emotional domains and physical concerns emphasized the importance of addressing both needs. Whilst the tooL does measure complexity, its value is limited in quantifying the appropriate nurse to patient ratio for lung cancer nurse workforce planning. The results of the work was presented at BTOG and LCNUK conferences and included in a lightning presentation at the UKLCC conference. DevelopmentaL Leadership Supported by a £5,000 educational grant from MSD, alongside £15,000 of LCNUK core funding, we launched a new leadership programme at the end of 2024. This initiative provides lung cancer nurse specialist member5 Wlth the opportunity to apply for funding to undertake NHS-approved leadership development, including the Mary Seacole, Rosalind Franklin, and King's Fund leadership programmes. These highLy respected courses enable members to build essential leadership capabilities such as strategic thinking. influencing skills. service improvement. and leading teams through change. Three members have successfully applied for the funding and are participating in the leadership programmes. By investing in leadership development. we aim to empower Lung cancer nurse specialists to drive innovation, strengthen clinical service5. and enhance the qualily of care delivered across the Lung cancer pathway. hePatientCornplexilyln51rumentlvll. PresentedattheRCN InternationalRe5earch conlerence,UniversityolSouthWal. Easlerncooperative OniologyGioup.In.d.l.ECOG PeiloimanieSlalu5ScaLe. 'MacmlllanCancerSupport.P0221. Concernslheckllsi- ideniifyingyourconcerns. Palllatlvecareconcerns HNAChe£kllst.Thomas,S.120181. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)
Trustees, Report | For the year ending January 2026 Education and clinical In 2025, we hosted an annual conference at The Radisson Edwardian Hotel, Heathrow. The conference attracted 327 attendees of which 129 were members of LCNUK. 96/0 of those who completed the evaLuation reported that the conference was relevant to their educationaL needs with similar numbers reporting that the information was well presented by knowledgeable and appropriate speakers. When asked to describe their conference experience delegates stated "informative" -educationaL". "interesting. -enjoyable", "networking" "fun" and °inspiring" as the most commonLy used words. The data represents a sLight improvement on the previous year. The conference was able to raise much needed funds in 2025 (£176,633 vs £105,180 in 2024) from the saLe of exhibition space. The organisation hosted six webinars in 2025 supported by funding from Astrazeneca- which members couLd attend Live or watch on-demand at their leisure. These incLuded: The role of the multidisciplinary approach for high risk lung cancer patients 2VOV2025 Charlotte Smith and Vasileios Kouritas TKI therapy in EGFR gene mutation lung cancers/ Interpreting clinical trials AListair Greystoke and Jennifer Ross 27/02/2025 Key learning from the BTOG annual conference 2025 Paula Shepherd and Shobhit Baijal 18/03/2025 Fit for Surgery Programme 29/04/2025 Babu Naidu and Bing Smith Small cell lung cancer 2210512025 Emma Halkyard and Adam Uprichard Considering and supporting the carers of people with lung cancer Julia McAdam and Nitin Palekar 3V07/2025 -AslraZeneca had no Inputintothecontentolthewebinarsand5peaker5electionand editorialcontrol restedexclusivelywith LCNUK In a bid to reach a wider pooL of Lung cancer nurses LCNUK aLso hosted the fi rst in a series of planned annual regional meetings. This first meeting was heLd in Bristol where LCNUK has identified a Lower ratio of members than other areas of the country. 41 individuals attended with 21 delegates and 6 speakers. 2 registered delegates failed to attend. The meeting sessions scored weLI for content and feedback was good. I r*¢411 Èn .J lém ,1 wsoré lfy ,.{ d d-,pk ¢rÈw IA re I ra oc s édérx Pk.1 of orL.,I Io s ¢ak lo kn. Lfrsés Ilgr of &l.yql Ik.¢ é5 ¢4 OrÈ IIMÈ for ¢4r Ikrou k Ig $ wÉlcOmÉ 9$ 1 COM seÉ¥A$ lo bÉ 1Crè9$1NyY Fk. $0 re s¢55iOMs. uÉ5 Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 Supported by funding from Astrazeneca LCNUK developed and impLemented an online Learning module on biomarker testing in NSCLC. We also commenced the development of a second Learning module on adverse event management of TKI toxicity which is due for completion in Q2 2026. OnLine learning moduLes provide a valuable way for our members to keep up to date with new practices and treatments and support ongoing professionaL development in their own time. Records of all completed modules are retained and members have the opportunity to download certificates of compLetion for thei r professionaL portfolios. LCNUK continues to support the annual award to recognise achievements of members. Communicating with our members LCNUK has continued to deliver short form easiLy-to-access succinct communications with members providing bite-size news and information that can be absorbed in the short window of time available to our members. To do this we continue to use social media to push out key messages, regularly update the content on our website with direct links from the home page to key important lung cancer and nursing news. We aLso prepare and deliver a monthly members newsletter featuring bite-size news and signposting members to educational and professionaL development information as weLI as updates on key lung cancer news and Links to other charity and not-for-profit news. Specialist Groups- Research and Thoracic Surgery LCNUK has two small workgroups of active members interested in research (known as RIG- Research Interest Group} and thoracic surgery (TSG). In 2025, Bing Smith took over as research lead of the RIG. CharLotte Smith continued to lead the TSG. The RIG has been contributing to research projects and supporting access to clinical trials. The group relaunched the small grants programme in 2025. Unfortunately, there have been no eligible appLications. Following the annual meeti ng in 2025 the RIG are focusi ng on, with the support of the Board of Trustees, the opportunity to develop a PhD programme and support members who wish to take the first steps in research to support the research element of the four nationally defined piLlars of advanced practice. There is a focus on integrating the activities of the RIG through closer collaboration on the annuaL workshop programme and other LCNUK activities. 27 abstracts were submitted to the LCNUK annual conference (vs 35 in 2024). Although this is a slight decline on 2024 there has been a steady increase in submissions since COVID and this remains signif icantly higher than pre-COVID years. The TSG have focused their work on a review of performance status in lung cancer. The outputs of their work have been shared through the Lung cancer community. The work reported that HCPS rely i n performance status assessments to make important clinical decisions but evidence suggests that there are newer tools which offer more objective, continuous. and muLtidimensional assessment compared to traditional Performance Status scales, but implementation chaLLenges remain around standardization, cost, and integration into clinicaL workflows.
Trustees, Report | For the year ending January 2026 Plans for future periods In 2026, LCNUK WILI be developing some new infographics to support nurses in the delivery of core treatments and care. We WILL be seeking to influence the national agenda to ensure that patients have appropriate access to Lung cancer nurse speciaLists so that they can act as the patients, ambassador and representative. We will continue to disseminate and share the lung cancer nurse and navigator professional frameworks which sets out the key skiLls and training required for the roles. We wilL be undertaking a programme ofwork on the impact of the National Optimal Lung cancer Pathway on lung cancer caseload for nurses. A further regionaL meeting is planned for November 2026 in the eastern midLands region. We are planning to introduce a "Nurse of the Year" award for members of LCNU We will continue to explore how best to support, foster and harness research and audit by Lung cancer nurse specialists and to share best practice and service development for the benefit of peopLe with lung cancer. We WILL support members who are working to achieve advanced clinical practitioner (ACP) status through our programme of activities which support all four piLlars. We WILL promote best practice through the sharing of cLinicaL knowledge and skills at our annual flagship two-day conference in June 2026. We will continue to work with partner organisations to promote best practice in Lung cancer nursing. We will continue to support member education with new online Learning modules, ongoing webinars and other digital learning which are now an estabLished feature and benefit of membership. We will continue to promote member communications. the sharing and dissemination of reLevant lung cancer news and information. We will continue to act as patient representatives and advocates at a national policy leveL. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 Structure, Governance & Management Constitution The charity is a registered charitable incorporated organisation, charity number 1160011. Formal membership is open to any lung cancer nurse specialist who spends more than 50/0 of their worki ng week or CLI n ical activities in caring for patients with lung cancer or mesothelioma. In addition, membership is open to nurse specialists in a lung cancer/mesothelioma academic or lung cancerlmesothelioma research role. Such membership is subject to approval by the LCNUK Committee. Associate membership is open to those who do not meet the criteria for formal membership. Method of appointment and election of trustees The management of the charity is the responsibility of the trustees who are elected and co- opted under the terms of the constitution. During this period the LCNUK was managed by seven trustees. Led by Diana Borthwick after being eLected the new chair by the board of trustees. The trustees, or any member of LCNUK can recommend a trustee for appointment. One third of the trustees retire each year and may be re-appointed. AppLicants are asked to provide a CV and covering statement. A shortlist is drawn up and interviewed by a panel appointed by the Board of Trustees. Four new trustees were co-opted by the board of trustees in early 2026. Vanessa Beattie, Karen Clayton, Sian Evans and Lavinia Magee; these ind ividuaLs wilL be put forward for election at the next annual general meeting of the charity. The new trustees bring expertise in NHS and Lung cancer nursing and Sian Evans joins with experience in human resources. John White and George Bate resigned in 2025. Policies adopted for the induction and training of trustees A trustee recruitment and induction pack is available to support new trustees i n learning about the organisation, its role, governance and responsi bilities of trustees. LCNUK is also a member of the National Council for VoLuntary Organisations to take advantage of governance training opportunities. The charity are introducing a buddy scheme for new trustees. Organisation structure and decision making The Trustees are assisted by the LCNUK Committee. The chair of the LCNUK committee attend5 trustee meetings to ensure continuity and good communications. During 2025 the committee was comprised of 13 elected members of LCNUK and three co-opted members. The LCNUK committee is responsible for the operational delivery of programmes and aLso formulates recommendations on the aims, strategies and activities of the charity for approval by the trustees. An agency, Red Hot Irons Limited (RHI), is contracted to run the day-to-day business administration and operations of the organisation supervised by the LCNUK committee. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 Pay Policy for key management There are no paid staff, all work undertaken by the committee and trustees is done so voluntarily. The support agency is contracted to run the operationaL day-to-day activities and business admi nistration. AppLication and adherence to the Charity Governance Code LCNUK recognise good governance is essential to our effectiveness, reputation and credi bility. The Board of Trustees regularly review activitie5, policies and processes to ensure the charity is delivering agai nst its mission and charitable objectives. We have robust measures in pLace to ensure effective and clear overview of financial controls. The board undertakes a regular review (every two years) of its effectiveness, assessing competencies, skiLLs gaps and train ing needs through a process of external audit and facilitated discussion. In 2025. LCNUK reviewed and updated its policies on privacy. safeguarding. antiharassment and bullying, discipli nary procedure for members. bribery, compliants, conflicts of interest, endorsement, procurement and representation. We also updated our poLicy for voLunteers. The investment and risk management policies were also reviewed as part of the routine governance of the organisation. We operate a robust conflicts of interest policy, and all Trustees and Committee members complete declarations of interest each year. Conflict of interests form a standing item on aLL committee/board agendas. The Board aims to continuously improve its governance processes and is currently working through the new Charity Governance Code to ensure its governance structures adhere to the principles of the code and recommended practice. While the charity receives funding and sponsorship from a range of pharmaceutical companies and legal f i rms in the lung cancer field, the Board of Trustees undertakes regular reviews to ensure that no single organisation exerts undue infLuence or creates an over-reliance. We have clear and robust policies in place to safeguard our independence, ensuring that all funding is accepted on the basis that it does not shape, compromise. or jeopardise the i ntegrity of our work or the best interests of the people we serve. Lung Cancer Nurslng e Incorporated organisation (ClOI- harity Number 116(M)11)
Trustees, Report | For the year ending January 2026 Risk management The Trustees anaLyse and undertake a review of the risks the Charity is exposed to as part of an annual business pLanning process and in accordance with Charity Commission guidar)ce (CC26), scoring the risks according to li kelihood and impact. The systems and actions established to mitigate those risk5 are also reviewed by Trustees at each Board meeting and updated and adjusted accordingly, with the net risk in each area agreed. H igh risks closely monitored by the Trustees are: High LeveL of dependency on too few income streams puts LCNUK at risk of sudden andlor Long-term loss of fundi ng- efforts continue to diversify income streams to incLude more Trusts and Foundation as well as funding from non-pharmaceutical companies. PotentiaL for a sudden drop in income and the need to dip into accumulated reserves The risk that LCNUK could be perceived a5 being unduly influenced by. sponsors/pharmaceuticaL industry. LCNUK has adopted a stringent endorsement policy and ensures where possi bLe that there is a balance of sponsors from across the industry spectrum with no one sponsor having significant influence or control. Sponsors are not permitted to have any form of editoriaL control or influence over the content and development of new LCNUK branded materiaLs. Volunteers The Society is heaviLy reLiant on the time, expertise and energy of its committee and other members. Much of the work of the charity is conducted virtually via email and teleconference and is undertaken on a voluntary basis. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011) io
Trustees, Report | For the year ending January 2026 Trustees, executive committee & senior management Tru5tee5 David BaLdwin George Bate (resigned 0110912025) Vanessa Beattie (co-opted Jan 2026) Diana Borthwick (resigned 07/06/2026) Karen CLayton (co-opted Jan 2026) Lorraine Creech Sian Evans (co-opted Jan 2026) Nicola HandLey Catherine Haywood Lavinia Magee (co-opted Jan 2026) Domin ic Smith (interim chair from 07106126) John White (resigned 1110612025) Registered office c/0 Dodd & Co, FIFTEEN Rosehill Montgomery Way Roseh ILL Estate CARLISLE CAI 2RW LCNUK Committee Karen CLayton (resigned June 2025) Pamela DalrympLe Marie Eaton Annabel Grinbergs (resigned May 2025) Emma HaLkyard (resigned Dec 2025) Maria Hill (elected October 2025) Karen Macrae (elected October 2025) Julia McAdam (Chair) Venencia Rayson (elected October 2025) Jenn ifer Ross Paula Shepherd Bing Smith Charlotte Smith Joanna Vick (elected October 2025) Jane Weir Kirstie Woods (elected October 2025, resigned ApriL 2026) Co-opted LCNUK Commillee members Peter Barton (LGBTQIA representative) Matthew KeLly (Nl representative) Natalie Bloodworth (Wales representative) Gemma Crowley (Wales representative) Bankers Unity Trust bank plc Nine Brindley Place Birmingham, Bl 2HB Charity Bank Fosse House, 182 High Street, Tonbridge, Kent TN9 IBE Charity Registered Number 1160011 Accountants Dodd & Co Chartered Accountants FI FTEEN RosehiLL Morltgomery Way RosehiLI Estate Carlisle CAI 2RW Nationwide Building Society Nationwide House, Pipers Way Swindon, SN38 INW Teachers BuiLding Society Allenview House, Hanham Road Wimborne, Dorset BH21 IAG Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011} li
Trustees, Report | For the year ending January 2026 Financial Review PrincipaL Income The principal fund ing sources for the Charity in 2025 as in previous years were.. Voluntary income from the pharmaceutical industry (fees from the LCNUK Corporate Sponsorshi p) Income f rom sponsorsh ip of charitable activities by commercial organisations Membership fees and conference registrations Total funding secured in 2025 was £255,052, an increase of 9.56Yo on the previous year. ALthough the charity was only able to secure one corporate sponsorship during the accounting period, add itional sponsorship for charitable activities helped offset this. Increased income from bank interest (£19,820 compared with £6,808 in 2024), generated through the introduction of new f ixed-rate accounts. also contributed to the overaLI upLift in funding. Together, these factors enabled us to achieve higher income than in 2024. Membership income (£8.400) was up on 2024 (£7.74fl) due to the increase in retention. PrincipaL Expenditure TotaL charitable expenditure in 2025 was £182.859, compared with £138,899 in 2024. This increase refLects the growth in charitable activity, incLuding an increase in the number of webinar5 delivered. additionaL online Learning modules produced. a new regional meeting was held, increased travel bursaries awarded, and higher committee costs (the committee has returned to face-to-face meetings rather than virtuaL formats). The national conference was aLso significantly more expensive in 2025 than in 2024, driven by substantial rises in venue fees that exceeded current inf lation rates. Support costs have risen by £15,201 in the fiscal year to £33,913. The largest item in support costs was secretariat, website and accountancy costs, which includes fees paid to Red Hot Irons. Red Hot I rons is contracted to run the day-to-day operations of the charity, including maintenance and upkeep of our website, membership management and communications, committee management, events, IT, webinar5, anaLytics and database. Reserves Policy LCNUK has no regular or guaranteed sources of income, and the Long-term financial sustainabi lity of the charity remains uncertain. Despite this, the charity must meet f ixed operating costs to maintain its activities, fulf IL its charitabLe objectives, and sustain its presence. Work is planned at least one year in advance, with some financiaL commitments - such as those relating to the annual conference- made up to two years ahead. The Trustees have therefore determined that, in order to safeguard the delivery of programmes in the event of a significant reduction in income, the charity should hold an opti mal reserve equivalent to 12 months of f ixed operating costs plus the annual cost of the conference. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011) 12
Trustees, Report | For the year ending January 2026 This level of reserve enables LCNU K to pursue its long-term strategy without being forced into short-term reactive decisions during temporary funding deficits. It also provides the flexi bility to take forward new opportunities that may require modest upfront investment. Minimum and maximum reserve Levels have been set at six months and eighteen months of operating costs respectively. The Trustees will only consider taking significant corrective action if reserves fall below the minimum threshoLd. and WILL onLy commit to major Long-term investments when reserves exceed the optimaL leveL. Based on the 2026 budget. the optimal reserve level is £226.664. with a minimum requirement of £113,332. At the end of the accounting period (January 2026), the Society held free reserves of £442,048, exceeding the optimal reserve target. The Board is now working with the committee to identify new and appropriate charitabLe-purpose programmes that can be supported using the surpLus reserves. The Board undertakes an annual review of the reserves policy to ensure it remains aLigned with the charity's activities and that the level of reserves is suff icient to meet f inancial and charitable obligations should funding decline for any reason. Going concern After making appropriate enquiries. the Trustees have a reasonable expectation that the charity has adequate resources to continue in operationaL existence for the foreseeabLe future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further detaiLs regarding the adoption of the going concern basis can be found in the accounting policies. Financial Review Conclusion The Society ended the year with an operating surplus of £38,280 for the accounting period. The charity continues to hold healthy free reserves which exceed the maximum reserves Level allowing the charity to undertake additional charitabLe programmes. However, sponsorship and funding remain a significant challenge and operating costs continue to rise particularly around venue hire charges and insurance costs. The Trustees recognise that the funding situation remains chalLenging, and WILL continue to be innovative in our approach to fundraising, cost savings and ensuring value for money. We WILL also Look to achieve additionaL funding from grant making bodies. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011} 13
Trustees, Report | For the year ending January 2026 Statement of Trustees, responsibilities The Trustees are responsibLe for preparing the Trustees, report and the financiaL statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Charity law requires the Trustees to prepare financial statements for each financiaL year. Under charity law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fai r view of the state of affairs of the Charity and of its incoming resources and application of resources, i ncluding its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to: seLect suitabLe accounting policies and then apply them consistently: observe the methods and principles of the Charities SORP (FRS 102)- make judgments and accounting estimates that are reasonable and prudent,. state whether applicable UK Accounting Standards {FRS 102) have been followed, subject to any materiaL departures d isclosed and explained in the f inancial statements,. prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business. The Trustees are responsible for keeping adequate accounting records that are sufficient to show and expLain the charity's transactions and discLose with reasonable accuracy at any time the financiaL position of the charity and enabLe them to ensure that the f inancial statements comply with the Charities Act 2011. They are aLso responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irreguLarities. Disclosure of information to independent examiners Each of the persons who are Trustees at the time when this Trustees, report is approved has conf irmed that.. so far as that Trustee is aware, there is no relevant information of which the charity's accountant and independent examiner are unaware, and that Trustee has taken alL the steps that ought to have been taken as a Trustee in order to be aware of any reLevant information and to establish that the charity's accountants are aware of that information. Approved by order of the members of the board of Trustees and signed on their behalf by.. Dominic Smith Interim Chair of the Board of Trustees Date.. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011) 14
Independent Examiner's Report to the Trustees of
Lung Cancer Nursing UK
I report on the accounts of the charity for the year ended 31 January 2026, which are set out on pages 16 to 23.
Your attention is drawn to the fact that the Charity has prepared the financial statements in accordance with Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has since been withdrawn.
We understand that this has been done in order for the accounts to provide a true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2019.
Respective responsibilities of trustees and examiner
The Charity's trustees are responsible for the preparation of the accounts. The trustees consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 as amended by the Charities Act 2022 (the Act) and that an independent examination is needed.
The charity's gross income exceeded £250,000 and I am qualified to undertake the examination by being a qualified member of the Institute of Chartered Accountants in England and Wales.
It is my responsibility to:
-
examine the accounts under section 145 of the Act;
-
follow the procedures laid down in the General Directions given by the Charity Commission under section 145 (5) (b) of the Act; and
-
state whether particular matters have come to my attention.
Basis of independent examiner's report
My examination was carried out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a 'true and fair view' and the report is limited to those matters set out in the statement below.
Independent examiner's statement
In connection with my examination, no matter has come to my attention:
-
(1) which gives me reasonable cause to believe that in any material respect the requirements:
-
to keep accounting records in accordance with section 130 of the Charities Act 2011 as amended by the Charities Act 2022; and
-
to prepare accounts which accord with the accounting records, comply with the accounting requirements of the Act
have not been met; or
- (2) to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached.
----- Start of picture text -----
.........................................
----- End of picture text -----
......................................... Joanne Thomlinson FCA Dodd & Co Limited Chartered Accountants
FIFTEEN Rosehill Montgomery Way Rosehill Estate CARLISLE CA1 2RW
26 May 2026
Page 15
Lung Cancer Nursing UK known as LCNUK Statement of Financial Activities for the Year Ended 31 January 2026 Unrestricted Total Fund¥ Totsl Fund¥ Funds 2026 2025 Note Income and endowments from: Donations and legacies Investtnenl income Charitable activities Total income 114 19,820 235.118 255,052 114 19,820 235.118 255.052 6,808 225.996 232,804 Expenditure on: Ch8rit8ble activities Total expenditure 216,772 216.772 216,772 218.772 157,611 157.611 Nel movements in funds 38,280 38,280 75,193 Reconciliation of funds Total funds brought forward Total funds carried forward 403,768 442,048 403,788 442,048 328,575 403,768 The notes on pages 18 10 24 form integral part of these fin8ncial staleTnent5. Page 16
Lung Cancer Nursing UK trading as LCNUK Balance Sheet as at 31 January 2026 2026 2025 Note Current assets Debtors Cash at bank and in hand 10 49,693 442.451 58,401 375.181 492,144 433,582 Creditors.. Amounts falling du• within one year 150,0961 {29,8141 Net current assets 442,048 403,768 Net assets 442,048 403,768 The funds of the charity= Unrestricted funds Unre51ricted income funds 442,048 403,768 Total charity funds 442,048 403,768 The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021. ApDroved by the Board on 26 May 2026 and signed on its behalf by.. D Smith Trustee The notes on pages 18 to 24 fomi an integral part of these financial ststements. Page 17
Lung Cancer Nursing UK known as LCNUK Notes to the Financial Statements for the Year Ended 31 January 2026 Accounting policies Statèmant of eomplianeè The accounts (financial statements) have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant notelsl to these accounts. The financial statements have been prepared in accordance wth the second edition of the Charities Statement of Recommended Practice issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland IFRS 1021 and the Charities Act 2011 as amended by the Charities Act 2022. The accounts Ifinancial statements) have been prepared to give a 'true and fairf view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair view,. This departure has involved following Accounting and Reporting by Charities preparing their accounts in accordan with the Finanaal Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 rather than the Accounting and Reporting by Charities'.Statement of Recommended Practice effective from 1 April 2005 which has since been withdrawn. Basis of preparation The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes. Going concern These financial statements have been prepared on a going concern basis.The trustees assess whether the use of going conrn is appropriate i.e. whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability ol the Charity to continue as a going concern. The trustees make this assessment in respect of a period of one year from the date of approval of the financial statements. Fund accounting policy Unrestricted income funds are general funds that are available for use at the trustees, discretion in furtherance of the objectives of the charity. Further details ol each fund are disclosed in note 13. Income and endowments Donations and legacies induding gifts are recognised where there is entitlement, probability of receipt and the amount can be measured with sufficient reliability. Income frorn Goveinmenl and other grants, whelher'¢apilal' grants or'revenue, grants, is recognised when the charity has entitlement to the fLJnd5. any performance conditions 8ttached to the grants have been mel, It Is piobable th8t the incotne will be received and the atnount be rneasured reliably and 15 not deferred. Investment income is recognised on a receivable basis. Income from charitable activities includes income recognised as earned las the related goods or services are provided) under contract. Membership income is recognised in the period it relates to. Page 18
Lung Cancer Nursing UK known as LCNUK Notes to the Financial Statements for the Year Ended 31 January 2026 . conh"rtued Expenditure Liabilities are recognised as soon as there is a legal or constructive obligation committing the charity to the expenditure. All expenditu is accounted for on an accruals basis and has been dassrfied under headings that aggregate all costs related to the category. Expenditure on raising funds are the sts of trading for fundraising purposes. Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them. Grants payable are payments made to third parties in the furtherance of the charitable objectives. Where the charity gives a grant with conditions ft>r its payment being a speerfic level ol service or output to be provided, such grants are only recognised in the SOFA once the reapient of the grant has provided the specific service or output. Grants payable without performance conditions are only recognised In the accounts when 8 Commitment has been made and there are no conditions to be mel relating to the grant which rernain in the conliol of the charity. Provisions for grants are made when the intention lo m8ke a gr8nt has been communicated to the recipient but there is uncertainty about either the timing of the grant or the amount of grant payable. Support costs Support costs include central functions and have been allocated to activity cost categories on a basis consistent with the use of resources, for example. allocating propety costs by floor areas, or per c8Pita, stsff costs by the lirne spent and other costs by their usage. Irrecoverable VAT Irrecoverable VAT is charged against the category of resources expended for which il was incurred. Cash and Cash Equivalents Cash and cash equivalents comprise cash on hand and call deposits, and other short-lemi highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. Restatement of comparatives The charity has reclassified certain income items from donations and legacies to charitable activities following a review of income presentation. This is a disdosur&only change and does not affect total income, net rnovement in funds, or the charity's financi81 position. Prior year comparatives have been reslaled accordingly lo ensure consistency wth the current yearfs presentation. Page 19
Lung Cancer Nursing UK known as LCNUK Notes to the Financial Statements for the Year Ended 31 January 2026 . conh"rtued Donatlons and legaeles Unrestrictad Total Funds Total Funds Funds 2026 2025 Donations and lègaciès Donations 114 114 In¥astm•nt ineomè Unr•striet•d Total Funds Total Funds Funds 2026 2025 Interest on cash deposits 19,820 19.820 6,808 01 the investment income in 2025 £e,808 related to unrestricted funds. Charitable activities Unrestricted Total Funds Totsl Funds Funds 2026 2025 Membershlp and research Membership subscriptions Corporate sponsorship Regional incotne Navigator group income 8,400 12.000 3,950 17 24,367 8,4QO 12.000 3,950 7,740 22.000 24.367 29,740 Annual conference Conference sponsorship collferen exhibition only Delegate registration 143,578 22,455 32.018 198,051 143.578 22,455 32,018 198,051 140,845 19,618 30,793 191,256 Online Education Leadership programme income Online Eduration Learning Modules Webinar Sponsorship 5.000 7,700 5,000 12,700 7,700 5,000 12.700 5,000 235,118 235.118 225,996 Page 20
Lung Cancer Nursing UK known as LCNUK Notes to the Financial Statements for the Year Ended 31 January 2026 . conh"rtued Of the incorne from tharilable activities in 2025 £225,996 related lo unreslrided funds. Expendlture Membershlp and research Annual conference Onllne Educatlon Total 2026 Total 2025 Direct costs Grants payable- individuals Webin81 Costs Leadership progratnrne expenditure Metnber5hip administration costs TSG committee costs Website costs N8vigalor group expenditure RIG costs Annual workshop Online learning Venue costs Speaker costs and tokens Management fees Conlerence costs- materials Conference costs- other 2,649 2.649 7,123 4,134 12,299 845 6.940 8,595 998 998 19841 5,846 4,455 12,533 1,061 4,328 570 1,936 8,333 2,708 43.664 3,444 11,500 20,068 19,437 138.899 7,123 4,134 12,299 845 6.940 8,595 998 998 80.559 80.559 2,946 12,000 23.724 19,049 182,859 12,000 23,724 19,049 140,927 30.675 11,257 Support costs Insurance Office management Committee costs Representation costs Sundry expenses Accountancy and bookkeeping fees Independent examinerfs fee Bank charges 285 5,026 3.439 279 285 5,026 3,438 278 285 5,026 3,438 278 104 855 15,078 10,315 835 312 828 7,591 3,055 324 1.754 1,754 1.754 5.262 4,835 650 1,429 18,712 216 202 11,305 217 202 11,304 217 202 11,304 650 606 33,913 41,980 152,231 22,561 218,772 157,611 Of the total expendituie in 2025 £157,611 related to unrestricted funds. Page 21
Lung Cancer Nursing UK known as LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
......... continued
6 Grantmaking
Grants to individuals £
Annual conference
2,649
7 Trustees' remuneration and expenses
Committee meeting and travel expenses totalling £283 (2025: £387) were paid to 2 (2025: 4) of the trustees during the year.
8 Taxation
The registered charity is exempt from taxation on income and gains.
9 Debtors
| Trade debtors Other debtors Prepayments and accrued income |
2026 £ 22,774 1,140 25,779 49,693 |
2025 £ - 7,453 50,948 |
|---|---|---|
| 58,401 |
10 Creditors: Amounts falling due within one year
| Trade creditors Other creditors Accruals and deferred income |
2026 £ 2,664 - 47,432 50,096 |
2025 £ 1,787 340 27,687 |
|---|---|---|
| 29,814 |
11 Related parties
Controlling entity
The charity is controlled by the trustees.
Page 22
Lung Cancer Nursing UK known as LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
......... continued
12 Analysis of funds
| General Funds Unrestricted income fund Prior year General Funds Unrestricted income fund |
At 1 February 2025 Incoming resources Resources expended £ £ £ 403,768 255,052 (216,772) At 1 February 2024 Incoming resources Resources expended £ £ £ 328,575 232,804 (157,611) |
At 31 January 2026 £ 442,048 |
|---|---|---|
| At 31 January 2025 £ 403,768 |
13 Net assets by fund
| Current assets Creditors: Amounts falling due within one year Net assets Prior year Current assets Creditors: Amounts falling due within one year Net assets |
Unrestricted Funds £ 492,144 (50,096) 442,048 Unrestricted funds £ 433,582 (29,814) 403,768 |
Total Funds 2026 £ 492,144 (50,096) 442,048 Total funds 2025 £ 433,582 (29,814) 403,768 |
Total Funds 2025 £ 433,582 (29,814) 403,768 Total funds 2024 £ 386,310 (57,735) 328,575 |
|---|---|---|---|
Page 23
LUNG CANCER NURSING UK WWW.LCNUK.ORG Phone: 01675 477607 EmaiL' info@lcnuk.org Correspondence address: 483 Green Lanes London N13 4BS •V Lung Cancer Nursing UK is a charitable incorporated organisation Charity number 1160011
LUNG CANCER NURSING UK Expl1n8 the expÈiien(# and nEe*il never 5moke5 With Lcitkwi LUNG CANCÈ 'NURSING Ihi Annual Report and Accounts Financial Year ending January 2026 li ancer Nursing UK | FIFTEEN Ro5ehi LSLE, CAI 2RW Mqnt te
Trustees, Report | For the year ending January 2026 About LCNUK Lung Cancer Nursing UK was estabLished in 1998 to support the advancement of health by providing nurses who specialise in the treatment of patients with Lung cancer or mesothelioma with support, education and the opportunity to communicate and network with peers.. and to provide a nationaL voice on clinical and strategic issues for specialist Lung cancer nurses. The organisation became a charitable incorporated organisation (CIO) in 2015. Membership is open to any specialist nurse who spends more than 50Vo of their working week or clinical activities in caring for patients with lung cancer and or mesothelioma. Associate membership is open to those who do not meet this criteria. The experience and clinical background of the members working environments are very diverse, including, palliative care, oncology (cancer centres or units) respiratory medicine, community and others, this affords the organisation a wealth of knowledge in to which members can access. The actlvltles of the CIO fall Into four dlstlnct categorfes these are as follow& Clinical Improving the care lung cancer patients receive Disseminating best practice and sharing information and knowledge DeveLopmental Keeping members up-to-date with the latest Lung cancer news through our e-buLletins Highlighting new developments in the UK Encouraging regional participation within LCNUK Education Providing a forum to disseminate new developments, skills, treatments and practice through educationaL programmes, annual conference, resources and pubLications Sharing cLinical updates and best practice with members Supporting and fostering audit and research in lung cancer and within the role of the LCNS Professional Provid ing support and networking, infrastructure and opportunities Campaigning for and supporting the role of the lung cancer nurse specialist Providing a voice on clinical and strategic issue5. H ighlighting the specialist role of nurses in cari ng for people with Lung cancer and mesothelioma Representing Lung cancer nurse speciaLists on nationaL and international bodies and organ isations Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 2025 Business Priorities The Trustees present their annual report together with the f inancial statements of the charity for the year l February 2025 to 31 January 2026. The Trustees confirm that the Annual Report and Financial Statements of the charity comply with the current statutory requirements, the requirements of the charity's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing thei r accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of IreLand {FRS102) (effective l January 2019). The Trustees have complied with the duty in part I section 4 of the Charities Act 2011 to have due regard to pubLic benefit guidance published by the Charity Commission. A detailed report of the activities undertaken and achievements by the Charity to further its charitable purposes for the public benef it is given below. In 2025 LCNUK had the following business priorities: ProfessionaL To act as advocates for patients with lung cancer on national professionaL bodies such as NICE/BTOG. To represent the Lung cancer nurse specialist on professional bodies and committees and provide a voice on strategic issues at a regional and national LeveL To promote the Lung cancer nurse specialist role and its benefits on an internationaL platform. To share best practice in lung cancer and mesothelioma care. DeveLopmentaL To ensure production and circulation of a monthLy e-bulleti n to share best practice and highlight lung cancer and reLevant nursing news and events. To maintain the LCNUK website creating, sharing and signposting to relevant news and events. Education and clinical Annual Conference June 2025 - To provide ongoing professional education to Lung cancer nurse speciaListS through its annual conference. To provide regular educationaL programmes of activity for members and associate members. Research To support ongoing research programmes with academic institutions and provide small research grants to support lung cancer nurse specialists taking their fi rst steps in research and those seeking advanced care practitioner status. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 2025 Impact report In 2025, workforce pressures continued relentlessly to impact on Lung Cancer Nurse Specialists. The UK Lung Cancer CoaLition (UKLCC) reported in 2025 that the lung cancer nurse specialist case Load typically ranges from 100 - 200 patients per nurse, and that this level is insufficient to meet demand. LCNUK has responded to these pressures by adapting its programmes and delivering education through short-form digital content, webinars and podcasts to support ongoing professional deveLopment. In spite of the challenges, the LCNUK annual conference continued to be weLL attended and is seen as a highlight of the professional year for our members. In 2025, we introduced associate membership for lung cancer navigators and developed a dedicated programme of education and practical tools to support this vital workforce incLuding a professional framework to guide Lung Cancer Navigators/Coordinators, their line managers and empLoyers on the core skiLLs, knowledge and training that they will gain and demonstrate as they progress in the role. Navigators play a key role alongside lung cancer nurse speciaLists in deliveri ng h igh-quality lung cancer care. They are an essentiaL part of the pathway, helping to ensure that patients, needs are prioritised and that their care journey is as seamless as possible. Membership numbers have increased sLightly in the business year and continue to hoLd strong following growth and increased retention after COVID. The charity is continuing to work on deveLoping innovative programmes to attract new members. Membership 2025 2024 2023 2022 2021 2020 2019 New 83 95 113 86 50. 82 Renewed 211 206 178 179 282. 156" 180 Expired/ cancelled 148 127 114 150 113 71 'Any member who paid for a membership in 2020, ha5 had their membership end dale extended to 2022 Professional Influencing and contribution to national poLicy LCNUK works alongside numerous organisations across the UK to inform lung cancer policy, promote best practice and act as the patients advocate for people with Lung cancer. In 2025, we continued to collaborate with national bodies including NICE, BTOG. UKLCC, Roy Castle Lung Cancer Foundation and other lung cancer related organisations to support the development of national policy and guideLines. The organisation has continued to support Lung Cancer Europe activities which have had number of initiatives taking pLace and members have submitted abstracts to the IASLC WorLd Conference on Lung Cancer. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 Representation British Thoracic Oncology Group GlobaL Lung Cancer Coalition I nternational Thoracic Oncology Nurses Forum Lung Cancer Europe Mesothelioma UK National Lung Cancer Audit National Institute for Health and Care Excellence Roy Castle Lung Cancer CoaLition Scottish Medicines Consortium Scottish Lung Cancer Nurses Forum UK Lung Cancer Coalition Welsh Lung Cancer Nurses Forum During 2025, LCNUK implemented a programme to evaLuate a tool to measure complexity in patients with lung cancer. The tool was assessed by group of members as part of the LCNUK annual workshop. The tool. based on The Patient Complexity Instrument" and the Macmillan Palliative Care Concerns HNA,, demonstrated that complexity increases with cancer stage and more nursing time is needed at stage 4. The strong correlation between emotional domains and physical concerns emphasized the importance of addressing both needs. Whilst the tooL does measure complexity, its value is limited in quantifying the appropriate nurse to patient ratio for lung cancer nurse workforce planning. The results of the work was presented at BTOG and LCNUK conferences and included in a lightning presentation at the UKLCC conference. DevelopmentaL Leadership Supported by a £5,000 educational grant from MSD, alongside £15,000 of LCNUK core funding, we launched a new leadership programme at the end of 2024. This initiative provides lung cancer nurse specialist member5 Wlth the opportunity to apply for funding to undertake NHS-approved leadership development, including the Mary Seacole, Rosalind Franklin, and King's Fund leadership programmes. These highLy respected courses enable members to build essential leadership capabilities such as strategic thinking. influencing skills. service improvement. and leading teams through change. Three members have successfully applied for the funding and are participating in the leadership programmes. By investing in leadership development. we aim to empower Lung cancer nurse specialists to drive innovation, strengthen clinical service5. and enhance the qualily of care delivered across the Lung cancer pathway. hePatientCornplexilyln51rumentlvll. PresentedattheRCN InternationalRe5earch conlerence,UniversityolSouthWal. Easlerncooperative OniologyGioup.In.d.l.ECOG PeiloimanieSlalu5ScaLe. 'MacmlllanCancerSupport.P0221. Concernslheckllsi- ideniifyingyourconcerns. Palllatlvecareconcerns HNAChe£kllst.Thomas,S.120181. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011)
Trustees, Report | For the year ending January 2026 Education and clinical In 2025, we hosted an annual conference at The Radisson Edwardian Hotel, Heathrow. The conference attracted 327 attendees of which 129 were members of LCNUK. 96/0 of those who completed the evaLuation reported that the conference was relevant to their educationaL needs with similar numbers reporting that the information was well presented by knowledgeable and appropriate speakers. When asked to describe their conference experience delegates stated "informative" -educationaL". "interesting. -enjoyable", "networking" "fun" and °inspiring" as the most commonLy used words. The data represents a sLight improvement on the previous year. The conference was able to raise much needed funds in 2025 (£176,633 vs £105,180 in 2024) from the saLe of exhibition space. The organisation hosted six webinars in 2025 supported by funding from Astrazeneca- which members couLd attend Live or watch on-demand at their leisure. These incLuded: The role of the multidisciplinary approach for high risk lung cancer patients 2VOV2025 Charlotte Smith and Vasileios Kouritas TKI therapy in EGFR gene mutation lung cancers/ Interpreting clinical trials AListair Greystoke and Jennifer Ross 27/02/2025 Key learning from the BTOG annual conference 2025 Paula Shepherd and Shobhit Baijal 18/03/2025 Fit for Surgery Programme 29/04/2025 Babu Naidu and Bing Smith Small cell lung cancer 2210512025 Emma Halkyard and Adam Uprichard Considering and supporting the carers of people with lung cancer Julia McAdam and Nitin Palekar 3V07/2025 -AslraZeneca had no Inputintothecontentolthewebinarsand5peaker5electionand editorialcontrol restedexclusivelywith LCNUK In a bid to reach a wider pooL of Lung cancer nurses LCNUK aLso hosted the fi rst in a series of planned annual regional meetings. This first meeting was heLd in Bristol where LCNUK has identified a Lower ratio of members than other areas of the country. 41 individuals attended with 21 delegates and 6 speakers. 2 registered delegates failed to attend. The meeting sessions scored weLI for content and feedback was good. I r*¢411 Èn .J lém ,1 wsoré lfy ,.{ d d-,pk ¢rÈw IA re I ra oc s édérx Pk.1 of orL.,I Io s ¢ak lo kn. Lfrsés Ilgr of &l.yql Ik.¢ é5 ¢4 OrÈ IIMÈ for ¢4r Ikrou k Ig $ wÉlcOmÉ 9$ 1 COM seÉ¥A$ lo bÉ 1Crè9$1NyY Fk. $0 re s¢55iOMs. uÉ5 Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 Supported by funding from Astrazeneca LCNUK developed and impLemented an online Learning module on biomarker testing in NSCLC. We also commenced the development of a second Learning module on adverse event management of TKI toxicity which is due for completion in Q2 2026. OnLine learning moduLes provide a valuable way for our members to keep up to date with new practices and treatments and support ongoing professionaL development in their own time. Records of all completed modules are retained and members have the opportunity to download certificates of compLetion for thei r professionaL portfolios. LCNUK continues to support the annual award to recognise achievements of members. Communicating with our members LCNUK has continued to deliver short form easiLy-to-access succinct communications with members providing bite-size news and information that can be absorbed in the short window of time available to our members. To do this we continue to use social media to push out key messages, regularly update the content on our website with direct links from the home page to key important lung cancer and nursing news. We aLso prepare and deliver a monthly members newsletter featuring bite-size news and signposting members to educational and professionaL development information as weLI as updates on key lung cancer news and Links to other charity and not-for-profit news. Specialist Groups- Research and Thoracic Surgery LCNUK has two small workgroups of active members interested in research (known as RIG- Research Interest Group} and thoracic surgery (TSG). In 2025, Bing Smith took over as research lead of the RIG. CharLotte Smith continued to lead the TSG. The RIG has been contributing to research projects and supporting access to clinical trials. The group relaunched the small grants programme in 2025. Unfortunately, there have been no eligible appLications. Following the annual meeti ng in 2025 the RIG are focusi ng on, with the support of the Board of Trustees, the opportunity to develop a PhD programme and support members who wish to take the first steps in research to support the research element of the four nationally defined piLlars of advanced practice. There is a focus on integrating the activities of the RIG through closer collaboration on the annuaL workshop programme and other LCNUK activities. 27 abstracts were submitted to the LCNUK annual conference (vs 35 in 2024). Although this is a slight decline on 2024 there has been a steady increase in submissions since COVID and this remains signif icantly higher than pre-COVID years. The TSG have focused their work on a review of performance status in lung cancer. The outputs of their work have been shared through the Lung cancer community. The work reported that HCPS rely i n performance status assessments to make important clinical decisions but evidence suggests that there are newer tools which offer more objective, continuous. and muLtidimensional assessment compared to traditional Performance Status scales, but implementation chaLLenges remain around standardization, cost, and integration into clinicaL workflows.
Trustees, Report | For the year ending January 2026 Plans for future periods In 2026, LCNUK WILI be developing some new infographics to support nurses in the delivery of core treatments and care. We WILL be seeking to influence the national agenda to ensure that patients have appropriate access to Lung cancer nurse speciaLists so that they can act as the patients, ambassador and representative. We will continue to disseminate and share the lung cancer nurse and navigator professional frameworks which sets out the key skiLls and training required for the roles. We wilL be undertaking a programme ofwork on the impact of the National Optimal Lung cancer Pathway on lung cancer caseload for nurses. A further regionaL meeting is planned for November 2026 in the eastern midLands region. We are planning to introduce a "Nurse of the Year" award for members of LCNU We will continue to explore how best to support, foster and harness research and audit by Lung cancer nurse specialists and to share best practice and service development for the benefit of peopLe with lung cancer. We WILL support members who are working to achieve advanced clinical practitioner (ACP) status through our programme of activities which support all four piLlars. We WILL promote best practice through the sharing of cLinicaL knowledge and skills at our annual flagship two-day conference in June 2026. We will continue to work with partner organisations to promote best practice in Lung cancer nursing. We will continue to support member education with new online Learning modules, ongoing webinars and other digital learning which are now an estabLished feature and benefit of membership. We will continue to promote member communications. the sharing and dissemination of reLevant lung cancer news and information. We will continue to act as patient representatives and advocates at a national policy leveL. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 Structure, Governance & Management Constitution The charity is a registered charitable incorporated organisation, charity number 1160011. Formal membership is open to any lung cancer nurse specialist who spends more than 50/0 of their worki ng week or CLI n ical activities in caring for patients with lung cancer or mesothelioma. In addition, membership is open to nurse specialists in a lung cancer/mesothelioma academic or lung cancerlmesothelioma research role. Such membership is subject to approval by the LCNUK Committee. Associate membership is open to those who do not meet the criteria for formal membership. Method of appointment and election of trustees The management of the charity is the responsibility of the trustees who are elected and co- opted under the terms of the constitution. During this period the LCNUK was managed by seven trustees. Led by Diana Borthwick after being eLected the new chair by the board of trustees. The trustees, or any member of LCNUK can recommend a trustee for appointment. One third of the trustees retire each year and may be re-appointed. AppLicants are asked to provide a CV and covering statement. A shortlist is drawn up and interviewed by a panel appointed by the Board of Trustees. Four new trustees were co-opted by the board of trustees in early 2026. Vanessa Beattie, Karen Clayton, Sian Evans and Lavinia Magee; these ind ividuaLs wilL be put forward for election at the next annual general meeting of the charity. The new trustees bring expertise in NHS and Lung cancer nursing and Sian Evans joins with experience in human resources. John White and George Bate resigned in 2025. Policies adopted for the induction and training of trustees A trustee recruitment and induction pack is available to support new trustees i n learning about the organisation, its role, governance and responsi bilities of trustees. LCNUK is also a member of the National Council for VoLuntary Organisations to take advantage of governance training opportunities. The charity are introducing a buddy scheme for new trustees. Organisation structure and decision making The Trustees are assisted by the LCNUK Committee. The chair of the LCNUK committee attend5 trustee meetings to ensure continuity and good communications. During 2025 the committee was comprised of 13 elected members of LCNUK and three co-opted members. The LCNUK committee is responsible for the operational delivery of programmes and aLso formulates recommendations on the aims, strategies and activities of the charity for approval by the trustees. An agency, Red Hot Irons Limited (RHI), is contracted to run the day-to-day business administration and operations of the organisation supervised by the LCNUK committee. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011}
Trustees, Report | For the year ending January 2026 Pay Policy for key management There are no paid staff, all work undertaken by the committee and trustees is done so voluntarily. The support agency is contracted to run the operationaL day-to-day activities and business admi nistration. AppLication and adherence to the Charity Governance Code LCNUK recognise good governance is essential to our effectiveness, reputation and credi bility. The Board of Trustees regularly review activitie5, policies and processes to ensure the charity is delivering agai nst its mission and charitable objectives. We have robust measures in pLace to ensure effective and clear overview of financial controls. The board undertakes a regular review (every two years) of its effectiveness, assessing competencies, skiLLs gaps and train ing needs through a process of external audit and facilitated discussion. In 2025. LCNUK reviewed and updated its policies on privacy. safeguarding. antiharassment and bullying, discipli nary procedure for members. bribery, compliants, conflicts of interest, endorsement, procurement and representation. We also updated our poLicy for voLunteers. The investment and risk management policies were also reviewed as part of the routine governance of the organisation. We operate a robust conflicts of interest policy, and all Trustees and Committee members complete declarations of interest each year. Conflict of interests form a standing item on aLL committee/board agendas. The Board aims to continuously improve its governance processes and is currently working through the new Charity Governance Code to ensure its governance structures adhere to the principles of the code and recommended practice. While the charity receives funding and sponsorship from a range of pharmaceutical companies and legal f i rms in the lung cancer field, the Board of Trustees undertakes regular reviews to ensure that no single organisation exerts undue infLuence or creates an over-reliance. We have clear and robust policies in place to safeguard our independence, ensuring that all funding is accepted on the basis that it does not shape, compromise. or jeopardise the i ntegrity of our work or the best interests of the people we serve. Lung Cancer Nurslng e Incorporated organisation (ClOI- harity Number 116(M)11)
Trustees, Report | For the year ending January 2026 Risk management The Trustees anaLyse and undertake a review of the risks the Charity is exposed to as part of an annual business pLanning process and in accordance with Charity Commission guidar)ce (CC26), scoring the risks according to li kelihood and impact. The systems and actions established to mitigate those risk5 are also reviewed by Trustees at each Board meeting and updated and adjusted accordingly, with the net risk in each area agreed. H igh risks closely monitored by the Trustees are: High LeveL of dependency on too few income streams puts LCNUK at risk of sudden andlor Long-term loss of fundi ng- efforts continue to diversify income streams to incLude more Trusts and Foundation as well as funding from non-pharmaceutical companies. PotentiaL for a sudden drop in income and the need to dip into accumulated reserves The risk that LCNUK could be perceived a5 being unduly influenced by. sponsors/pharmaceuticaL industry. LCNUK has adopted a stringent endorsement policy and ensures where possi bLe that there is a balance of sponsors from across the industry spectrum with no one sponsor having significant influence or control. Sponsors are not permitted to have any form of editoriaL control or influence over the content and development of new LCNUK branded materiaLs. Volunteers The Society is heaviLy reLiant on the time, expertise and energy of its committee and other members. Much of the work of the charity is conducted virtually via email and teleconference and is undertaken on a voluntary basis. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011) io
Trustees, Report | For the year ending January 2026 Trustees, executive committee & senior management Tru5tee5 David BaLdwin George Bate (resigned 0110912025) Vanessa Beattie (co-opted Jan 2026) Diana Borthwick (resigned 07/06/2026) Karen CLayton (co-opted Jan 2026) Lorraine Creech Sian Evans (co-opted Jan 2026) Nicola HandLey Catherine Haywood Lavinia Magee (co-opted Jan 2026) Domin ic Smith (interim chair from 07106126) John White (resigned 1110612025) Registered office c/0 Dodd & Co, FIFTEEN Rosehill Montgomery Way Roseh ILL Estate CARLISLE CAI 2RW LCNUK Committee Karen CLayton (resigned June 2025) Pamela DalrympLe Marie Eaton Annabel Grinbergs (resigned May 2025) Emma HaLkyard (resigned Dec 2025) Maria Hill (elected October 2025) Karen Macrae (elected October 2025) Julia McAdam (Chair) Venencia Rayson (elected October 2025) Jenn ifer Ross Paula Shepherd Bing Smith Charlotte Smith Joanna Vick (elected October 2025) Jane Weir Kirstie Woods (elected October 2025, resigned ApriL 2026) Co-opted LCNUK Commillee members Peter Barton (LGBTQIA representative) Matthew KeLly (Nl representative) Natalie Bloodworth (Wales representative) Gemma Crowley (Wales representative) Bankers Unity Trust bank plc Nine Brindley Place Birmingham, Bl 2HB Charity Bank Fosse House, 182 High Street, Tonbridge, Kent TN9 IBE Charity Registered Number 1160011 Accountants Dodd & Co Chartered Accountants FI FTEEN RosehiLL Morltgomery Way RosehiLI Estate Carlisle CAI 2RW Nationwide Building Society Nationwide House, Pipers Way Swindon, SN38 INW Teachers BuiLding Society Allenview House, Hanham Road Wimborne, Dorset BH21 IAG Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011} li
Trustees, Report | For the year ending January 2026 Financial Review PrincipaL Income The principal fund ing sources for the Charity in 2025 as in previous years were.. Voluntary income from the pharmaceutical industry (fees from the LCNUK Corporate Sponsorshi p) Income f rom sponsorsh ip of charitable activities by commercial organisations Membership fees and conference registrations Total funding secured in 2025 was £255,052, an increase of 9.56Yo on the previous year. ALthough the charity was only able to secure one corporate sponsorship during the accounting period, add itional sponsorship for charitable activities helped offset this. Increased income from bank interest (£19,820 compared with £6,808 in 2024), generated through the introduction of new f ixed-rate accounts. also contributed to the overaLI upLift in funding. Together, these factors enabled us to achieve higher income than in 2024. Membership income (£8.400) was up on 2024 (£7.74fl) due to the increase in retention. PrincipaL Expenditure TotaL charitable expenditure in 2025 was £182.859, compared with £138,899 in 2024. This increase refLects the growth in charitable activity, incLuding an increase in the number of webinar5 delivered. additionaL online Learning modules produced. a new regional meeting was held, increased travel bursaries awarded, and higher committee costs (the committee has returned to face-to-face meetings rather than virtuaL formats). The national conference was aLso significantly more expensive in 2025 than in 2024, driven by substantial rises in venue fees that exceeded current inf lation rates. Support costs have risen by £15,201 in the fiscal year to £33,913. The largest item in support costs was secretariat, website and accountancy costs, which includes fees paid to Red Hot Irons. Red Hot I rons is contracted to run the day-to-day operations of the charity, including maintenance and upkeep of our website, membership management and communications, committee management, events, IT, webinar5, anaLytics and database. Reserves Policy LCNUK has no regular or guaranteed sources of income, and the Long-term financial sustainabi lity of the charity remains uncertain. Despite this, the charity must meet f ixed operating costs to maintain its activities, fulf IL its charitabLe objectives, and sustain its presence. Work is planned at least one year in advance, with some financiaL commitments - such as those relating to the annual conference- made up to two years ahead. The Trustees have therefore determined that, in order to safeguard the delivery of programmes in the event of a significant reduction in income, the charity should hold an opti mal reserve equivalent to 12 months of f ixed operating costs plus the annual cost of the conference. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011) 12
Trustees, Report | For the year ending January 2026 This level of reserve enables LCNU K to pursue its long-term strategy without being forced into short-term reactive decisions during temporary funding deficits. It also provides the flexi bility to take forward new opportunities that may require modest upfront investment. Minimum and maximum reserve Levels have been set at six months and eighteen months of operating costs respectively. The Trustees will only consider taking significant corrective action if reserves fall below the minimum threshoLd. and WILL onLy commit to major Long-term investments when reserves exceed the optimaL leveL. Based on the 2026 budget. the optimal reserve level is £226.664. with a minimum requirement of £113,332. At the end of the accounting period (January 2026), the Society held free reserves of £442,048, exceeding the optimal reserve target. The Board is now working with the committee to identify new and appropriate charitabLe-purpose programmes that can be supported using the surpLus reserves. The Board undertakes an annual review of the reserves policy to ensure it remains aLigned with the charity's activities and that the level of reserves is suff icient to meet f inancial and charitable obligations should funding decline for any reason. Going concern After making appropriate enquiries. the Trustees have a reasonable expectation that the charity has adequate resources to continue in operationaL existence for the foreseeabLe future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further detaiLs regarding the adoption of the going concern basis can be found in the accounting policies. Financial Review Conclusion The Society ended the year with an operating surplus of £38,280 for the accounting period. The charity continues to hold healthy free reserves which exceed the maximum reserves Level allowing the charity to undertake additional charitabLe programmes. However, sponsorship and funding remain a significant challenge and operating costs continue to rise particularly around venue hire charges and insurance costs. The Trustees recognise that the funding situation remains chalLenging, and WILL continue to be innovative in our approach to fundraising, cost savings and ensuring value for money. We WILL also Look to achieve additionaL funding from grant making bodies. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011} 13
Trustees, Report | For the year ending January 2026 Statement of Trustees, responsibilities The Trustees are responsibLe for preparing the Trustees, report and the financiaL statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Charity law requires the Trustees to prepare financial statements for each financiaL year. Under charity law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fai r view of the state of affairs of the Charity and of its incoming resources and application of resources, i ncluding its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to: seLect suitabLe accounting policies and then apply them consistently: observe the methods and principles of the Charities SORP (FRS 102)- make judgments and accounting estimates that are reasonable and prudent,. state whether applicable UK Accounting Standards {FRS 102) have been followed, subject to any materiaL departures d isclosed and explained in the f inancial statements,. prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business. The Trustees are responsible for keeping adequate accounting records that are sufficient to show and expLain the charity's transactions and discLose with reasonable accuracy at any time the financiaL position of the charity and enabLe them to ensure that the f inancial statements comply with the Charities Act 2011. They are aLso responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irreguLarities. Disclosure of information to independent examiners Each of the persons who are Trustees at the time when this Trustees, report is approved has conf irmed that.. so far as that Trustee is aware, there is no relevant information of which the charity's accountant and independent examiner are unaware, and that Trustee has taken alL the steps that ought to have been taken as a Trustee in order to be aware of any reLevant information and to establish that the charity's accountants are aware of that information. Approved by order of the members of the board of Trustees and signed on their behalf by.. Dominic Smith Interim Chair of the Board of Trustees Date.. Lung Cancer Nursing UK I A charitable incorporated organisation (CIO- Charity Number 1160011) 14
Independent Examiner's Report to the Trustees of
Lung Cancer Nursing UK
I report on the accounts of the charity for the year ended 31 January 2026, which are set out on pages 16 to 23.
Your attention is drawn to the fact that the Charity has prepared the financial statements in accordance with Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has since been withdrawn.
We understand that this has been done in order for the accounts to provide a true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2019.
Respective responsibilities of trustees and examiner
The Charity's trustees are responsible for the preparation of the accounts. The trustees consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 as amended by the Charities Act 2022 (the Act) and that an independent examination is needed.
The charity's gross income exceeded £250,000 and I am qualified to undertake the examination by being a qualified member of the Institute of Chartered Accountants in England and Wales.
It is my responsibility to:
-
examine the accounts under section 145 of the Act;
-
follow the procedures laid down in the General Directions given by the Charity Commission under section 145 (5) (b) of the Act; and
-
state whether particular matters have come to my attention.
Basis of independent examiner's report
My examination was carried out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit and consequently no opinion is given as to whether the accounts present a 'true and fair view' and the report is limited to those matters set out in the statement below.
Independent examiner's statement
In connection with my examination, no matter has come to my attention:
-
(1) which gives me reasonable cause to believe that in any material respect the requirements:
-
to keep accounting records in accordance with section 130 of the Charities Act 2011 as amended by the Charities Act 2022; and
-
to prepare accounts which accord with the accounting records, comply with the accounting requirements of the Act
have not been met; or
- (2) to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached.
----- Start of picture text -----
.........................................
----- End of picture text -----
......................................... Joanne Thomlinson FCA Dodd & Co Limited Chartered Accountants
FIFTEEN Rosehill Montgomery Way Rosehill Estate CARLISLE CA1 2RW
26 May 2026
Page 15
Lung Cancer Nursing UK known as LCNUK Statement of Financial Activities for the Year Ended 31 January 2026 Unrestricted Total Fund¥ Totsl Fund¥ Funds 2026 2025 Note Income and endowments from: Donations and legacies Investtnenl income Charitable activities Total income 114 19,820 235.118 255,052 114 19,820 235.118 255.052 6,808 225.996 232,804 Expenditure on: Ch8rit8ble activities Total expenditure 216,772 216.772 216,772 218.772 157,611 157.611 Nel movements in funds 38,280 38,280 75,193 Reconciliation of funds Total funds brought forward Total funds carried forward 403,768 442,048 403,788 442,048 328,575 403,768 The notes on pages 18 10 24 form integral part of these fin8ncial staleTnent5. Page 16
Lung Cancer Nursing UK trading as LCNUK Balance Sheet as at 31 January 2026 2026 2025 Note Current assets Debtors Cash at bank and in hand 10 49,693 442.451 58,401 375.181 492,144 433,582 Creditors.. Amounts falling du• within one year 150,0961 {29,8141 Net current assets 442,048 403,768 Net assets 442,048 403,768 The funds of the charity= Unrestricted funds Unre51ricted income funds 442,048 403,768 Total charity funds 442,048 403,768 The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021. ApDroved by the Board on 26 May 2026 and signed on its behalf by.. D Smith Trustee The notes on pages 18 to 24 fomi an integral part of these financial ststements. Page 17
Lung Cancer Nursing UK known as LCNUK Notes to the Financial Statements for the Year Ended 31 January 2026 Accounting policies Statèmant of eomplianeè The accounts (financial statements) have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant notelsl to these accounts. The financial statements have been prepared in accordance wth the second edition of the Charities Statement of Recommended Practice issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland IFRS 1021 and the Charities Act 2011 as amended by the Charities Act 2022. The accounts Ifinancial statements) have been prepared to give a 'true and fairf view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair view,. This departure has involved following Accounting and Reporting by Charities preparing their accounts in accordan with the Finanaal Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 rather than the Accounting and Reporting by Charities'.Statement of Recommended Practice effective from 1 April 2005 which has since been withdrawn. Basis of preparation The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes. Going concern These financial statements have been prepared on a going concern basis.The trustees assess whether the use of going conrn is appropriate i.e. whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability ol the Charity to continue as a going concern. The trustees make this assessment in respect of a period of one year from the date of approval of the financial statements. Fund accounting policy Unrestricted income funds are general funds that are available for use at the trustees, discretion in furtherance of the objectives of the charity. Further details ol each fund are disclosed in note 13. Income and endowments Donations and legacies induding gifts are recognised where there is entitlement, probability of receipt and the amount can be measured with sufficient reliability. Income frorn Goveinmenl and other grants, whelher'¢apilal' grants or'revenue, grants, is recognised when the charity has entitlement to the fLJnd5. any performance conditions 8ttached to the grants have been mel, It Is piobable th8t the incotne will be received and the atnount be rneasured reliably and 15 not deferred. Investment income is recognised on a receivable basis. Income from charitable activities includes income recognised as earned las the related goods or services are provided) under contract. Membership income is recognised in the period it relates to. Page 18
Lung Cancer Nursing UK known as LCNUK Notes to the Financial Statements for the Year Ended 31 January 2026 . conh"rtued Expenditure Liabilities are recognised as soon as there is a legal or constructive obligation committing the charity to the expenditure. All expenditu is accounted for on an accruals basis and has been dassrfied under headings that aggregate all costs related to the category. Expenditure on raising funds are the sts of trading for fundraising purposes. Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them. Grants payable are payments made to third parties in the furtherance of the charitable objectives. Where the charity gives a grant with conditions ft>r its payment being a speerfic level ol service or output to be provided, such grants are only recognised in the SOFA once the reapient of the grant has provided the specific service or output. Grants payable without performance conditions are only recognised In the accounts when 8 Commitment has been made and there are no conditions to be mel relating to the grant which rernain in the conliol of the charity. Provisions for grants are made when the intention lo m8ke a gr8nt has been communicated to the recipient but there is uncertainty about either the timing of the grant or the amount of grant payable. Support costs Support costs include central functions and have been allocated to activity cost categories on a basis consistent with the use of resources, for example. allocating propety costs by floor areas, or per c8Pita, stsff costs by the lirne spent and other costs by their usage. Irrecoverable VAT Irrecoverable VAT is charged against the category of resources expended for which il was incurred. Cash and Cash Equivalents Cash and cash equivalents comprise cash on hand and call deposits, and other short-lemi highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. Restatement of comparatives The charity has reclassified certain income items from donations and legacies to charitable activities following a review of income presentation. This is a disdosur&only change and does not affect total income, net rnovement in funds, or the charity's financi81 position. Prior year comparatives have been reslaled accordingly lo ensure consistency wth the current yearfs presentation. Page 19
Lung Cancer Nursing UK known as LCNUK Notes to the Financial Statements for the Year Ended 31 January 2026 . conh"rtued Donatlons and legaeles Unrestrictad Total Funds Total Funds Funds 2026 2025 Donations and lègaciès Donations 114 114 In¥astm•nt ineomè Unr•striet•d Total Funds Total Funds Funds 2026 2025 Interest on cash deposits 19,820 19.820 6,808 01 the investment income in 2025 £e,808 related to unrestricted funds. Charitable activities Unrestricted Total Funds Totsl Funds Funds 2026 2025 Membershlp and research Membership subscriptions Corporate sponsorship Regional incotne Navigator group income 8,400 12.000 3,950 17 24,367 8,4QO 12.000 3,950 7,740 22.000 24.367 29,740 Annual conference Conference sponsorship collferen exhibition only Delegate registration 143,578 22,455 32.018 198,051 143.578 22,455 32,018 198,051 140,845 19,618 30,793 191,256 Online Education Leadership programme income Online Eduration Learning Modules Webinar Sponsorship 5.000 7,700 5,000 12,700 7,700 5,000 12.700 5,000 235,118 235.118 225,996 Page 20
Lung Cancer Nursing UK known as LCNUK Notes to the Financial Statements for the Year Ended 31 January 2026 . conh"rtued Of the incorne from tharilable activities in 2025 £225,996 related lo unreslrided funds. Expendlture Membershlp and research Annual conference Onllne Educatlon Total 2026 Total 2025 Direct costs Grants payable- individuals Webin81 Costs Leadership progratnrne expenditure Metnber5hip administration costs TSG committee costs Website costs N8vigalor group expenditure RIG costs Annual workshop Online learning Venue costs Speaker costs and tokens Management fees Conlerence costs- materials Conference costs- other 2,649 2.649 7,123 4,134 12,299 845 6.940 8,595 998 998 19841 5,846 4,455 12,533 1,061 4,328 570 1,936 8,333 2,708 43.664 3,444 11,500 20,068 19,437 138.899 7,123 4,134 12,299 845 6.940 8,595 998 998 80.559 80.559 2,946 12,000 23.724 19,049 182,859 12,000 23,724 19,049 140,927 30.675 11,257 Support costs Insurance Office management Committee costs Representation costs Sundry expenses Accountancy and bookkeeping fees Independent examinerfs fee Bank charges 285 5,026 3.439 279 285 5,026 3,438 278 285 5,026 3,438 278 104 855 15,078 10,315 835 312 828 7,591 3,055 324 1.754 1,754 1.754 5.262 4,835 650 1,429 18,712 216 202 11,305 217 202 11,304 217 202 11,304 650 606 33,913 41,980 152,231 22,561 218,772 157,611 Of the total expendituie in 2025 £157,611 related to unrestricted funds. Page 21
Lung Cancer Nursing UK known as LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
......... continued
6 Grantmaking
Grants to individuals £
Annual conference
2,649
7 Trustees' remuneration and expenses
Committee meeting and travel expenses totalling £283 (2025: £387) were paid to 2 (2025: 4) of the trustees during the year.
8 Taxation
The registered charity is exempt from taxation on income and gains.
9 Debtors
| Trade debtors Other debtors Prepayments and accrued income |
2026 £ 22,774 1,140 25,779 49,693 |
2025 £ - 7,453 50,948 |
|---|---|---|
| 58,401 |
10 Creditors: Amounts falling due within one year
| Trade creditors Other creditors Accruals and deferred income |
2026 £ 2,664 - 47,432 50,096 |
2025 £ 1,787 340 27,687 |
|---|---|---|
| 29,814 |
11 Related parties
Controlling entity
The charity is controlled by the trustees.
Page 22
Lung Cancer Nursing UK known as LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2026
......... continued
12 Analysis of funds
| General Funds Unrestricted income fund Prior year General Funds Unrestricted income fund |
At 1 February 2025 Incoming resources Resources expended £ £ £ 403,768 255,052 (216,772) At 1 February 2024 Incoming resources Resources expended £ £ £ 328,575 232,804 (157,611) |
At 31 January 2026 £ 442,048 |
|---|---|---|
| At 31 January 2025 £ 403,768 |
13 Net assets by fund
| Current assets Creditors: Amounts falling due within one year Net assets Prior year Current assets Creditors: Amounts falling due within one year Net assets |
Unrestricted Funds £ 492,144 (50,096) 442,048 Unrestricted funds £ 433,582 (29,814) 403,768 |
Total Funds 2026 £ 492,144 (50,096) 442,048 Total funds 2025 £ 433,582 (29,814) 403,768 |
Total Funds 2025 £ 433,582 (29,814) 403,768 Total funds 2024 £ 386,310 (57,735) 328,575 |
|---|---|---|---|
Page 23
LUNG CANCER NURSING UK WWW.LCNUK.ORG Phone: 01675 477607 EmaiL' info@lcnuk.org Correspondence address: 483 Green Lanes London N13 4BS •V Lung Cancer Nursing UK is a charitable incorporated organisation Charity number 1160011